Dr. James Douglas Battiste, MD, PhD

Dr. Battiste practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Battiste's NPI, 1538368881, was assigned on July 17, 2007. Dr. Battiste graduated from UT Southwestern Medical Center in 2007. Dr. Battiste's Texas license number on file is N4286.

Dr. Battiste's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

Dr. Battiste's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Battiste is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Battiste to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Battiste practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Battiste's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Battiste is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Battiste's licenses on file in 2 states: Texas and Oklahoma.

Dmand AI lists neuropathy, parkinson's disease and sleep apnea among the conditions Dr. Battiste treats.

CMS data shows 202 Medicare services from Dr. Battiste across 4 procedure codes in 2024, all of them office visits, for 107 Medicare patients. Medicare paid $16,535 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 107 Medicare patients who saw Dr. Battiste in 2024. The largest group is 65 to 74, with 49 patients. 60% of them have high cholesterol, and 57% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Battiste's median patient age at 62, with 49% women.

In 2024, Dr. Battiste wrote 685 Medicare Part D claims for 104 patients. 75% of them were for generic drugs. CMS names the drug for 449 of them, across 17 drugs with 11 or more claims each, at $2,008,874 in total drug cost. In 2023, CMS named 497 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Battiste for performance year 2024, reported as part of a group. Dr. Battiste accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Battiste as offering telehealth.

Dmand AI links 61 papers to Dr. Battiste, published from 2004 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Brain Neoplasms, Glioblastoma and Cell Line, Tumor. Dr. Battiste has published most often in Neurooncol Adv. Dr. Battiste's most frequent co-authors are Michael Edward Sughrue, MD, Andrew Conner, MD and Chad Glenn, MD.

Dmand AI links Dr. Battiste to 10 clinical trials, 5 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Gliosarcoma. National Cancer Institute (NCI) sponsors the most, 5.

CMS Open Payments shows 115 general payments to Dr. Battiste from 26 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 49% of the total. Novocure Inc. paid the most, $9,608. It also lists 1 research payment totaling $45 in 2016.

Dr. Battiste graduated from UT Southwestern Medical Center in 2007.

Dr. Battiste is in network with 12 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.